These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12588780)

  • 1. Systematic family screening for familial hypercholesterolemia in Iceland.
    Thorsson B; Sigurdsson G; Gudnason V
    Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):335-8. PubMed ID: 12588780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review.
    Groselj U; Kovac J; Sustar U; Mlinaric M; Fras Z; Podkrajsek KT; Battelino T
    Atherosclerosis; 2018 Oct; 277():383-391. PubMed ID: 30270075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia.
    Ellis KL; Pérez de Isla L; Alonso R; Fuentes F; Watts GF; Mata P
    J Am Coll Cardiol; 2019 Mar; 73(9):1029-1039. PubMed ID: 30846097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detecting familial hypercholesterolemia by serum lipid profile screening in a hospital setting: Clinical, genetic and atherosclerotic burden profile.
    Scicali R; Di Pino A; Platania R; Purrazzo G; Ferrara V; Giannone A; Urbano F; Filippello A; Rapisarda V; Farruggia E; Piro S; Rabuazzo AM; Purrello F
    Nutr Metab Cardiovasc Dis; 2018 Jan; 28(1):35-43. PubMed ID: 28958694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reverse cascade screening for familial hypercholesterolemia in high-risk Chinese families.
    Wu X; Pang J; Wang X; Peng J; Chen Y; Wang S; Watts GF; Lin J
    Clin Cardiol; 2017 Nov; 40(11):1169-1173. PubMed ID: 29168983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An APEX-based genotyping microarray for the screening of 168 mutations associated with familial hypercholesterolemia.
    Dušková L; Kopečková L; Jansová E; Tichý L; Freiberger T; Zapletalová P; Soška V; Ravčuková B; Fajkusová L
    Atherosclerosis; 2011 May; 216(1):139-45. PubMed ID: 21310417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reaching detection targets in familial hypercholesterolaemia: Comparison of identification strategies.
    Wald DS; Bestwick JP
    Atherosclerosis; 2020 Jan; 293():57-61. PubMed ID: 31837509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screening.
    Leren TP; Finborud TH; Manshaus TE; Ose L; Berge KE
    Community Genet; 2008; 11(1):26-35. PubMed ID: 18196915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing.
    Humphries SE; Cranston T; Allen M; Middleton-Price H; Fernandez MC; Senior V; Hawe E; Iversen A; Wray R; Crook MA; Wierzbicki AS
    J Mol Med (Berl); 2006 Mar; 84(3):203-14. PubMed ID: 16389549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics.
    Williams RR; Hunt SC; Schumacher MC; Hegele RA; Leppert MF; Ludwig EH; Hopkins PN
    Am J Cardiol; 1993 Jul; 72(2):171-6. PubMed ID: 8328379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tracing of patients with familial hypercholesterolemia in the Netherlands].
    Umans-Eckenhausen MA; Defesche JC; Scheerder RL; Cliné F; Kastelein JJ
    Ned Tijdschr Geneeskd; 1999 May; 143(22):1157-61. PubMed ID: 10371839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No certain predictors for mutation status in a Danish cohort with familial hypercholesterolemia: a descriptive study.
    Nybo M; Brusgaard K; Hansen AB
    Clin Biochem; 2007 Dec; 40(18):1347-52. PubMed ID: 17961529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations.
    Havndrup O; Bundgaard H; Andersen PS; Allan Larsen L; Vuust J; Kjeldsen K; Christiansen M
    Cardiovasc Res; 2003 Feb; 57(2):347-57. PubMed ID: 12566107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic screening for familial hypercholesterolemia in 1992-1997: primarily younger patients in the care of family physicians].
    ten Asbroek AH; van Lunsen S; Marang-van de Mheen PJ; Gunning-Schepers LJ
    Ned Tijdschr Geneeskd; 2000 Jan; 144(3):125-9. PubMed ID: 10674119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal diagnosis of familial hypercholesterolemia in newborns born to a parent with a molecularly defined heterozygous familial hypercholesterolemia.
    Vuorio AF; Turtola H; Kontula K
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3332-7. PubMed ID: 9409330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reverse Cascade Screening for Familial Hypercholesterolemia.
    Vinson A; Guerra L; Hamilton L; Wilson DP; Fnla
    J Pediatr Nurs; 2019; 44():50-55. PubMed ID: 30683281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of clinical and laboratory parameters used in the identification of index cases for genetic screening of familial hypercholesterolemia in Brazil.
    Silva PRS; Jannes CE; Oliveira TGM; Miname MH; Rocha VZ; Chacra AP; Gurgel MHC; Montenegro RM; Rodrigues Sobrinho CRM; Bello Moreira AS; Assad MHV; Pinto MRC; Tada MT; Santos RD; Pereira AC; Krieger JE
    Atherosclerosis; 2017 Aug; 263():257-262. PubMed ID: 28689098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cascade screening of familial hypercholesterolemia must go on.
    Galema-Boers JM; Versmissen J; Roeters van Lennep HW; Dusault-Wijkstra JE; Williams M; Roeters van Lennep JE
    Atherosclerosis; 2015 Oct; 242(2):415-7. PubMed ID: 26282946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in The Netherlands.
    Wonderling D; Umans-Eckenhausen MA; Marks D; Defesche JC; Kastelein JJ; Thorogood M
    Semin Vasc Med; 2004 Feb; 4(1):97-104. PubMed ID: 15199439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
    Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
    Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.